140 related articles for article (PubMed ID: 37261851)
1. Kemps PG, Picarsic J, Durham BH, et al. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood. 2022;139(2):256-280.
Blood; 2023 Jun; 141(22):2785-2786. PubMed ID: 37261851
[No Abstract] [Full Text] [Related]
2. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
Kemps PG; Picarsic J; Durham BH; Hélias-Rodzewicz Z; Hiemcke-Jiwa L; van den Bos C; van de Wetering MD; van Noesel CJM; van Laar JAM; Verdijk RM; Flucke UE; Hogendoorn PCW; Woei-A-Jin FJSH; Sciot R; Beilken A; Feuerhake F; Ebinger M; Möhle R; Fend F; Bornemann A; Wiegering V; Ernestus K; Méry T; Gryniewicz-Kwiatkowska O; Dembowska-Baginska B; Evseev DA; Potapenko V; Baykov VV; Gaspari S; Rossi S; Gessi M; Tamburrini G; Héritier S; Donadieu J; Bonneau-Lagacherie J; Lamaison C; Farnault L; Fraitag S; Jullié ML; Haroche J; Collin M; Allotey J; Madni M; Turner K; Picton S; Barbaro PM; Poulin A; Tam IS; El Demellawy D; Empringham B; Whitlock JA; Raghunathan A; Swanson AA; Suchi M; Brandt JM; Yaseen NR; Weinstein JL; Eldem I; Sisk BA; Sridhar V; Atkinson M; Massoth LR; Hornick JL; Alexandrescu S; Yeo KK; Petrova-Drus K; Peeke SZ; Muñoz-Arcos LS; Leino DG; Grier DD; Lorsbach R; Roy S; Kumar AR; Garg S; Tiwari N; Schafernak KT; Henry MM; van Halteren AGS; Abla O; Diamond EL; Emile JF
Blood; 2022 Jan; 139(2):256-280. PubMed ID: 34727172
[TBL] [Abstract][Full Text] [Related]
3. ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology.
Kashima J; Yoshida M; Jimbo K; Izutsu K; Ushiku T; Yonemori K; Yoshida A
Am J Surg Pathol; 2021 Mar; 45(3):347-355. PubMed ID: 32826530
[TBL] [Abstract][Full Text] [Related]
4. Failure of crizotinib based systemic treatment in ALK positive histiocytosis involving the central nervous system: a case report and literature review.
He Q; Zhang W; Li Q
BMC Pediatr; 2022 May; 22(1):308. PubMed ID: 35614430
[TBL] [Abstract][Full Text] [Related]
5. Distinct Clinicopathologic Features and Possible Pathogenesis of Localized ALK-positive Histiocytosis of the Breast.
Osako T; Kurisaki-Arakawa A; Dobashi A; Togashi Y; Baba S; Shiozawa S; Ishigame H; Ishige H; Ohno S; Ishikawa Y; Takeuchi K
Am J Surg Pathol; 2022 Mar; 46(3):344-352. PubMed ID: 34482333
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic lymphoma kinase-positive histiocytosis with multisystem involvement: A case report.
Tu Y; Lu Y
Pediatr Dermatol; 2024; 41(3):551-553. PubMed ID: 38346136
[TBL] [Abstract][Full Text] [Related]
7. Local ALK-Positive Histiocytosis With Unusual Morphology and Novel
Tran TAN; Chang KTE; Kuick CH; Goh JY; Chang CC
Int J Surg Pathol; 2021 Aug; 29(5):543-549. PubMed ID: 33243034
[TBL] [Abstract][Full Text] [Related]
8. ALK-rearranged histiocytosis: Report of two cases with involvement of the central nervous system.
Rossi S; Gessi M; Barresi S; Tamburrini G; Giovannoni I; Ruggiero A; Colafati GS; Frassanito P; Carboni A; Alexandre A; Cacchione A; Trombatore P; Diomedi-Camassei F; Gaspari S; Gianno F; Marras CE; Cecinati V; Carai A; Mastronuzzi A; Alaggio R
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):878-881. PubMed ID: 34048085
[TBL] [Abstract][Full Text] [Related]
9. Expanding the Phenotype of ALK-positive Histiocytosis: A Report of 2 Cases.
Huang H; Gheorghe G; North PE; Suchi M
Pediatr Dev Pathol; 2018; 21(5):449-455. PubMed ID: 29224419
[TBL] [Abstract][Full Text] [Related]
10. [ALK positive histiocytosis with multiple system involvement: report of a case].
Yao S; Zhang F; Chen Y; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):495-497. PubMed ID: 38678335
[TBL] [Abstract][Full Text] [Related]
11. ALK-positive histiocytosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: a multitarget response under ibrutinib.
Syrykh C; Ysebaert L; Péricart S; Evrard SM; Meggetto F; Kanoun S; Brousset P; Laurent C
Virchows Arch; 2021 Apr; 478(4):779-783. PubMed ID: 33011863
[TBL] [Abstract][Full Text] [Related]
12. Disseminated ALK-positive histiocytosis with
Qiu L; Weitzman SP; Nastoupil LJ; Williams MD; Medeiros LJ; Vega F
Leuk Lymphoma; 2021 May; 62(5):1234-1238. PubMed ID: 33353436
[No Abstract] [Full Text] [Related]
13. ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion.
Chang KTE; Tay AZE; Kuick CH; Chen H; Algar E; Taubenheim N; Campbell J; Mechinaud F; Campbell M; Super L; Chantranuwat C; Yuen ST; Chan JKC; Chow CW
Mod Pathol; 2019 May; 32(5):598-608. PubMed ID: 30573850
[TBL] [Abstract][Full Text] [Related]
14. ALK-positive histiocytosis with
Gupta GK; Xi L; Pack SD; Jones JB; Pittaluga S; Raffeld M; Jaffe ES
Haematologica; 2019 Nov; 104(11):e534-e536. PubMed ID: 31371408
[No Abstract] [Full Text] [Related]
15. Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.
Durham BH; Lopez Rodrigo E; Picarsic J; Abramson D; Rotemberg V; De Munck S; Pannecoucke E; Lu SX; Pastore A; Yoshimi A; Mandelker D; Ceyhan-Birsoy O; Ulaner GA; Walsh M; Yabe M; Petrova-Drus K; Arcila ME; Ladanyi M; Solit DB; Berger MF; Hyman DM; Lacouture ME; Erickson C; Saganty R; Ki M; Dunkel IJ; Santa-María López V; Mora J; Haroche J; Emile JF; Decaux O; Geissmann F; Savvides SN; Drilon A; Diamond EL; Abdel-Wahab O
Nat Med; 2019 Dec; 25(12):1839-1842. PubMed ID: 31768065
[TBL] [Abstract][Full Text] [Related]
16. Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes.
Lee LH; Gasilina A; Roychoudhury J; Clark J; McCormack FX; Pressey J; Grimley MS; Lorsbach R; Ali S; Bailey M; Stephens P; Ross JS; Miller VA; Nassar NN; Kumar AR
JCI Insight; 2017 Feb; 2(3):e89473. PubMed ID: 28194436
[TBL] [Abstract][Full Text] [Related]
17. A male infant with ALK-positive histiocytosis recovered spontaneously.
Xu Z; Huang L; Xue R
Clin Exp Dermatol; 2024 May; 49(6):620-622. PubMed ID: 38240038
[No Abstract] [Full Text] [Related]
18. Multisystem ALK-positive histiocytosis: a multi-case study and literature review.
Liu W; Liu HJ; Wang WY; Tang Y; Zhao S; Zhang WY; Yan JQ; Liu WP
Orphanet J Rare Dis; 2023 Mar; 18(1):53. PubMed ID: 36915094
[TBL] [Abstract][Full Text] [Related]
19. Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
Pearson ADJ; Barry E; Mossé YP; Ligas F; Bird N; de Rojas T; Zimmerman ZF; Wilner K; Woessmann W; Weiner S; Weigel B; Venkatramani R; Valteau D; Trahair T; Smith M; Singh S; Selvaggi G; Scobie N; Schleiermacher G; Richardson N; Park J; Nysom K; Norga K; Merino M; McDonough J; Matloub Y; Marshall LV; Lowe E; Lesa G; Irwin M; Karres D; Gajjar A; Doz F; Fox E; DuBois SG; Donoghue M; Casanova M; Caron H; Buenger V; Bradford D; Blanc P; Barone A; Reaman G; Vassal G
Eur J Cancer; 2021 Nov; 157():198-213. PubMed ID: 34536944
[TBL] [Abstract][Full Text] [Related]
20. Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma.
Melchers RC; Willemze R; van de Loo M; van Doorn R; Jansen PM; Cleven AHG; Solleveld N; Bekkenk MW; van Kester MS; Diercks GFH; Vermeer MH; Quint KD
Am J Surg Pathol; 2020 Jun; 44(6):776-781. PubMed ID: 32412717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
